| 4.63 Delayed Data As of 4:00pm ET |  -0.11 / -2.32%Today’s Change | 4.01 Today|||52-Week Range 51.60 | -87.42% Year-to-Date |
| 2 Growth Stocks for In-the-Know Investors Oct 01 / MotleyFool.com - Paid Partner Content | Are Options Traders Betting on a Big Move in Novavax (NVAX) Stock? Sep 17 / Zacks.com - Paid Partner Content |
| Previous close | 4.74 |
| Today’s open | 4.78 |
| Day’s range | 4.55 - 4.79 |
| Volume | 425,453 |
| Average volume (3 months) | 811,184 |
| Market cap | $109.1M |
| Earnings growth (last year) | +20.69% |
| Earnings growth (this year) | +45.10% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +9.98% |
| P/E ratio | NM |
| Price/Sales | 19.84 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| JNCEJounce Therapeutics ... | +0.01 | +0.29% |
| BTAIBioXcel Therapeutics... | -0.43 | -6.90% |
| CYADCelyad SA | +0.06 | +0.67% |
| APTOAptose Biosciences I... | +0.04 | +2.07% |
| Next reporting date | November 7, 2019 |
| EPS forecast (this quarter) | -$0.85 |
| Annual revenue (last year) | $34.3M |
| Annual profit (last year) | -$184.7M |
| Net profit margin | -538.81% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Gaithersburg, Maryland |
